CIK 0001811063
- Non-accelerated filer
- Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850862255
- Phone
- +1 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 150,000 shares at $7.82 ($1,173,255)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at an average $7.75 ($155,000)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 369,051 shares at $7.23 ($2,667,132)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at $7.00 ($140,074)
- 4 Open-market sale CHIEF TECHNICAL OPERATIONS sold 200,000 shares at $7.14 ($1,427,680)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 30,000 shares at an average $4.93 ($148,028)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 100,000 shares at $5.02 ($502,460)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 10,000 shares at $1.71 ($17,100)
- 4 Open-market buy Chief Financial Officer bought 7,300 shares at an average $1.81 ($13,216)
- 4 Open-market buy Chief Commercial Officer bought 50,000 shares at $1.81 ($90,350)
- 4 Open-market buy CHIEF REGULATORY OFFICER bought 50,000 shares at an average $1.79 ($89,740)
- 4 Open-market buy PRESIDENT AND CEO bought 500,000 shares at $1.79 ($893,500)
- 4 Derivatives Options or other derivatives
Page 2 of 10 · 184 filings